The Lancet presents the interim results of CoronaVac
The Lancet presented the interim results of a double-blind, randomised, controlled trial of CoronaVac versus placebo in Turkey. Adults aged 18–59 years who were seronegative and RT-PCR-negative for SARS-CoV-2 infection received two doses of…